SCHEMBL2216919

SCHEMBL2216919

ON=C1CCc2ccccc2NC1=NO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.47
▸ MAPK13 O15264 1/20 0.47
▸ MAPK12 P53778 1/20 0.47
▸ MAPK11 Q15759 1/20 0.47
▸ MAPK14 Q16539 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.44
▸ MAPT P10636 3/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.38
▸ PTK2B Q14289 1/20 0.38
▸ CYP1A2 P05177 2/20 0.36
▸ AHR P35869 1/20 0.36
▸ PDK2 Q15119 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2217338 0.81 NPC1 (0.55) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL3456349 0.81 NPC1 (0.55) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL9372759 0.76 NPC1 (0.52) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL407439 0.73 NPC1 (0.70) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL1201517 0.69 HPGD (0.77) NPC1ALDH1A1MAPTMEN1KMT2A
SCHEMBL2733083 0.69 HPGD (0.77) NPC1ALDH1A1MAPTMEN1KMT2A
SCHEMBL29453066 0.69 HPGD (0.77) NPC1ALDH1A1MAPTMEN1KMT2A
SCHEMBL1201521 0.69 HPGD (0.77) NPC1ALDH1A1MAPTMEN1KMT2A
SCHEMBL29417938 0.69 HPGD (0.77) NPC1ALDH1A1MAPTMEN1KMT2A
SCHEMBL9688137 0.69 NPC1 (0.57) NPC1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345908-B1 PROCESS FOR THE PREPARATION OF ALPHA-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES MERCK PATENT GMBH (DE) 2011-07-27 — — EP disclosed
EP-2256104-A1 Process for the preparation of alpha-aminosubstituted carboxylic acid amides Merck Patent GmbH (DE) 2010-12-01 — — EP disclosed
US-7166720-B2 Process for the preparation of α-aminosubstituted carboxylic acid amides MERCK PATENT GESELLSCHAFT (DE) 2007-01-23 — — US disclosed
US-7053211-B2 Process for the preparation of α-aminosubstituted carboxylic acid amides MERCK PATENT GMBH (DE) 2006-05-30 — — US disclosed
US-20060025587-A1 Process for the preparation of alpha-aminosubstituted carboxylic acid amides HARTIG THORSTEN 2006-02-02 — — US disclosed
US-20040034250-A1 Process for the preparation of alpha-aminosubstituted carboxylic acid amides MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2004-02-19 — — US disclosed
EP-1345908-A2 PROCESS FOR THE PREPARATION OF ALPHA-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES MERCK PATENT GmbH (DE) 2003-09-24 — — EP disclosed
WO-2002051813-A2 PROCESS FOR THE PREPARATION OF α-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES MERCK PATENT GMBH (DE) 2002-07-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034250-A1 Process for the preparation of alpha-aminosubstituted carboxylic acid amides ASNS, HNMT, NAAA NPC1 4246/4885MAPK13 3000/4885MAPK12 2388/4885
US-20060025587-A1 Process for the preparation of alpha-aminosubstituted carboxylic acid amides ASNS, HNMT, AASDHPPT NPC1 4088/4885MAPK13 3195/4885MAPK12 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback